BUD31 AND LIPID METABOLISM: A NEW POTENTIAL TERAPEUTIC ENTRY POINT FOR MYC-DRIVEN BREAST CANCER

$469,500FY2014Department of DefenseDOD

Baylor College Of Medicine, Houston TX

Investigators